Showing results (1761-1770 of 1,873) with videos related to

Sort By:
Pageof 188
European Journal of Heart Failure|September 29, 2023
Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trialAnkeet S Bhatt, Mikhail N Kosiborod, Brian L Claggett, et al.
European Journal of Heart Failure|June 20, 2020
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trialAdriaan A Voors, Jean-François Tamby, John G Cleland, et al.
The New England Journal of Medicine|September 1, 2006
Celecoxib for the prevention of sporadic colorectal adenomasMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
JACC. Basic to Translational Science|March 13, 2023
Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR TrialViviany R Taqueti, Amil M Shah, Brendan M Everett, et al.
Science Immunology|May 2, 2025
Distinct type I and II interferon responses direct cortical and medullary thymic epithelial cell developmentAbdulvasey Mohammed, Wenqing Wang, Martin Arreola, et al.
The Lancet. Diabetes & Endocrinology|December 2, 2021
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trialsPeter Rossing, Silvio E Inzucchi, Priya Vart, et al.
European Heart Journal|August 27, 2022
Dapagliflozin for heart failure according to body mass index: the DELIVER trialCarly Adamson, Toru Kondo, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 12, 2018
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the AmericasPooja Dewan, Pardeep S Jhund, Li Shen, et al.
American Heart Journal|April 2, 2025
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney diseaseKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Lisbet Brandi, et al.
European Heart Journal|June 30, 2016
Geographic variations in the PARADIGM-HF heart failure trialSøren Lund Kristensen, Felipe Martinez, Pardeep S Jhund, et al.
Pageof 188